SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-055883
Filing Date
2023-07-10
Accepted
2023-07-10 17:20:17
Documents
13
Period of Report
2023-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181491-8k_enzobio.htm   iXBRL 8-K 30184
2 AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT, DATED AS OF JULY 3, 2023, BY AND AM ea181491ex2-1_enzobio.htm EX-2.1 54570
  Complete submission text file 0001213900-23-055883.txt   268490

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE enz-20230703_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE enz-20230703_pre.xml EX-101.PRE 22350
5 XBRL SCHEMA FILE enz-20230703.xsd EX-101.SCH 2944
7 EXTRACTED XBRL INSTANCE DOCUMENT ea181491-8k_enzobio_htm.xml XML 3477
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 231080598
SIC: 8071 Services-Medical Laboratories